Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSTG
3651
DELISTED
Biostage, Inc. Common Stock
BSTG
| $929K | ﹤0.01% |
285,879
+21,225
| +8% | +$72.3K |
|
|
VIA
3652
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $924K | ﹤0.01% |
25,067
-35,640
| -59% | -$1.3M |
|
3653
Espey Mfg & Electronics Corp
ESP
$186M
| $923K | ﹤0.01% |
31,666
+800
| +3% | +$21.7K |
|
|
PPIH
3654
Perma-Pipe International
PPIH
$210M
| $916K | ﹤0.01% |
146,560
+1,500
| +1% | +$9.35K |
|
|
HH
3655
DELISTED
Hooper Holmes Inc
HH
| $914K | ﹤0.01% |
117,232
+154
| +0.1% | +$1.22K |
|
|
SMMF
3656
DELISTED
Summit Financial Group, Inc.
SMMF
| $909K | ﹤0.01% |
76,054
+700
| +0.9% | +$8.14K |
|
|
CARM
3657
DELISTED
Carisma Therapeutics
CARM
| $908K | ﹤0.01% |
5,090
+337
| +7% | +$73.6K |
|
3658
FS Bancorp
FSBW
$324M
| $908K | ﹤0.01% |
95,084
| – | – |
|
3659
Comstock
LODE
$233M
| $898K | ﹤0.01% |
5,981
+106
| +2% | +$21.9K |
|
|
IMI
3660
DELISTED
Intermolecular, Inc.
IMI
| $897K | ﹤0.01% |
547,232
+99,600
| +22% | +$170K |
|
|
REED
3661
DELISTED
Reeds, Inc. Common Stock
REED
| $889K | ﹤0.01% |
3,182
+68
| +2% | +$19.5K |
|
3662
Mannatech
MTEX
$9.44M
| $888K | ﹤0.01% |
47,870
+3,165
| +7% | +$67.6K |
|
|
GSB
3663
DELISTED
GlobalSCAPE, Inc.
GSB
| $888K | ﹤0.01% |
259,613
+5,084
| +2% | +$14.7K |
|
3664
RCM Technologies
RCMT
$205M
| $887K | ﹤0.01% |
132,340
+4,309
| +3% | +$27.2K |
|
|
SPDC
3665
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
| $886K | ﹤0.01% |
1,387,647
+127,073
| +10% | +$195K |
|
|
ITI
3666
DELISTED
Iteris, Inc.
ITI
| $884K | ﹤0.01% |
485,750
+5,100
| +1% | +$9.04K |
|
3667
Fate Therapeutics
FATE
$287M
| $883K | ﹤0.01% |
180,638
+8,700
| +5% | +$43.1K |
|
3668
Atossa Therapeutics
ATOS
$22.6M
| $882K | ﹤0.01% |
181
+11
| +6% | +$46.9K |
|
|
GV
3669
DELISTED
Goldfield Corporation
GV
| $881K | ﹤0.01% |
454,201
+40,220
| +10% | +$98.3K |
|
|
NRCIB
3670
DELISTED
National Research Corp Class B
NRCIB
| $881K | ﹤0.01% |
27,528
+1,556
| +6% | +$52.4K |
|
|
CIFC
3671
DELISTED
CIFC LLC Common Shares
CIFC
| $879K | ﹤0.01% |
114,999
-100
| -0.1% | -$825 |
|
3672
Vanguard Consumer Discretionary ETF
VCR
$6.25B
| $876K | ﹤0.01% |
7,153
+3,070
| +75% | +$365K |
|
|
SUMR
3673
DELISTED
Summer Infant, Inc.
SUMR
| $870K | ﹤0.01% |
35,790
+33
| +0.1% | +$878 |
|
|
TAT
3674
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $868K | ﹤0.01% |
162,491
+15,497
| +11% | +$74.8K |
|
|
OXGN
3675
DELISTED
OXIGENE INC COM
OXGN
| $866K | ﹤0.01% |
593,678
+63,537
| +12% | +$105K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.